| Price | 10.50p on 10-02-2026 at 08:00:38 |
|---|---|
| Change | -0.50p -4.55% |
| Buy | 11.00p |
| Sell | 10.00p |
| Last Trade: | Sell 56,000.00 at 10.126p |
| Day's Volume: | 0 |
| Last Close: | 11.00p |
| Open: | 10.50p |
| ISIN: | GB00BYV81293 |
| Day's Range | 10.50p - 10.50p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £112.14m |
| VWAP: | 0.00p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 56,000 | 10.126p | Ordinary |
14:02:20 - 09-Feb-26 |
| Sell* | 80,000 | 10.10p | Uncrossing Trade |
14:00:18 - 09-Feb-26 |
| Sell* | 4,938 | 10.126p | Ordinary |
12:57:23 - 09-Feb-26 |
| Unknown* | 241,080 | 10.37p | Ordinary |
12:56:35 - 09-Feb-26 |
| Buy* | 9,401 | 10.50p | Ordinary |
12:55:12 - 09-Feb-26 |
| Sell* | 60 | 10.00p | SI Trade |
12:55:11 - 09-Feb-26 |
| Buy* | 9,821 | 10.50p | SI Trade |
12:55:11 - 09-Feb-26 |
| Buy* | 18,000 | 10.20p | Ordinary |
12:47:38 - 09-Feb-26 |
| Unknown* | 20,000 | 10.00p | Ordinary |
12:42:15 - 09-Feb-26 |
| Unknown* | 2,960 | 10.00p | Ordinary |
12:37:36 - 09-Feb-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
| 2nd Jan 2026 11:06 am | RNS | Block listing 6 Monthly Return |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 18th Dec 2025 7:13 am | RNS | Block Listing Application |
